We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
(-11%)
Cap. Flow
-$3.05B
Cap. Flow
% of AUM
-17.25%
Top 10 Holdings %
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$113M |
| 2 |
BERY
Berry Global Group, Inc.
BERY
|
+$106M |
| 3 |
Merck
MRK
|
+$95.9M |
| 4 |
Baidu
BIDU
|
+$85.8M |
| 5 |
IQVIA
IQV
|
+$83.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$229M |
| 2 |
Las Vegas Sands
LVS
|
+$150M |
| 3 |
Alibaba
BABA
|
+$131M |
| 4 |
Citigroup
C
|
+$130M |
| 5 |
Micron Technology
MU
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.85% |
| 2 | Technology | 15.39% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 10.48% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Interparfums
IPAR
$3.94B
| $904K | 0.01% |
16,905
-153,032
| -90% | -$7.79M |
|
|
NSLR
952
Neostellar Capital Corp
NSLR
$254M
| $903K | 0.01% |
156,814
+17,390
| +12% | +$102K |
|
|
KIN
953
DELISTED
Kindred Biosciences, Inc.
KIN
| $903K | 0.01% |
+84,825
| New | +$827K |
|
954
Cavco Industries
CVCO
$4.55B
| $900K | 0.01% |
+4,333
| New | +$814K |
|
955
Euronet Worldwide
EEFT
$2.7B
| $900K | 0.01% |
+10,738
| New | +$869K |
|
956
EverQuote
EVER
$906M
| $898K | 0.01% |
+49,586
| New | +$896K |
|
|
OXFD
957
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $898K | 0.01% |
+69,663
| New | +$941K |
|
|
TVPT
958
DELISTED
Travelport Worldwide Limited
TVPT
| $898K | 0.01% |
48,409
+11,588
| +31% | +$203K |
|
959
Outfront Media
OUT
$5.5B
| $892K | 0.01% |
46,590
+24,461
| +111% | +$465K |
|
960
East-West Bancorp
EWBC
$18B
| $889K | 0.01% |
13,629
-187,358
| -93% | -$12.7M |
|
961
POSCO
PKX
$17.5B
| $889K | 0.01% |
+11,999
| New | +$971K |
|
962
Sanofi
SNY
$104B
| $879K | 0.01% |
21,976
-368,405
| -94% | -$14.5M |
|
963
AngioDynamics
ANGO
$649M
| $876K | ﹤0.01% |
39,391
-12,205
| -24% | -$249K |
|
|
CERN
964
DELISTED
Cerner Corp
CERN
| $864K | ﹤0.01% |
14,447
-328,490
| -96% | -$19.4M |
|
|
SASR
965
DELISTED
Sandy Spring Bancorp Inc
SASR
| $863K | ﹤0.01% |
+21,047
| New | +$861K |
|
966
Packaging Corp of America
PKG
$22.8B
| $862K | ﹤0.01% |
7,708
-36,590
| -83% | -$4.27M |
|
|
ACER
967
DELISTED
Acer Therapeutics Inc
ACER
| $861K | ﹤0.01% |
39,872
+19,800
| +99% | +$376K |
|
|
KRA
968
DELISTED
Kraton Corporation
KRA
| $859K | ﹤0.01% |
18,625
-11,686
| -39% | -$567K |
|
969
Trane Technologies
TT
$106B
| $857K | ﹤0.01% |
9,553
-540,575
| -98% | -$47.5M |
|
970
Gildan
GIL
$10.6B
| $855K | ﹤0.01% |
30,361
-19,981
| -40% | -$580K |
|
|
LOVE
971
LoveSac
LOVE
$261M
| $855K | ﹤0.01% |
+41,187
| New | +$907K |
|
|
EGOV
972
DELISTED
NIC Inc
EGOV
| $854K | ﹤0.01% |
+54,948
| New | +$835K |
|
|
PS
973
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $850K | ﹤0.01% |
+34,775
| New | +$835K |
|
974
NMI Holdings
NMIH
$3.36B
| $847K | ﹤0.01% |
51,996
-322,040
| -86% | -$5.22M |
|
975
CRA International
CRAI
$1.06B
| $840K | ﹤0.01% |
16,506
-17,499
| -51% | -$962K |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2018 Portfolio in Review
As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.
- Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
- Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
- Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
- Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
- Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
- Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
- Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.
Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.